INCREASED ANGIOTENSIN CONVERTING ENZYME IN MURINE SCHISTOSOMIASIS - EFFECTS OF CAPTOPRIL AND MK-421

被引：0
|
作者：
SILVERSTEIN, E
EVELAND, LK
FRIEDLAND, J
STANEK, AE
DIAMOND, HS
BUSH, ME
COHEN, L
机构：
[1] SUNY DOWNSTATE MED CTR,DEPT MED,BROOKLYN,NY 11203
[2] SUNY DOWNSTATE MED CTR,DEPT PATHOL,BROOKLYN,NY 11203
[3] SUNY DOWNSTATE MED CTR,DEPT MICROBIOL & IMMUNOL,BROOKLYN,NY 11203
来源：
CLINICAL RESEARCH | 1982年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A404 / A404
页数：1
相关论文
共 50 条
  • [1] CAPTOPRIL AND MK-421 INHIBIT ANGIOTENSIN CONVERTING ENZYME (ACE) IN BLOOD-VESSELS FROM SHR
    COHEN, ML
    KURZ, KD
    WILEY, KS
    FEDERATION PROCEEDINGS, 1982, 41 (05) : 1666 - 1666
  • [2] COMPARATIVE INHIBITION OF ANGIOTENSIN CONVERTING ENZYME (ACE) IN TISSUES OF SHR AFTER CAPTOPRIL (C) AND MK-421
    KURZ, KD
    COHEN, ML
    WILEY, KS
    SMITH, T
    FEDERATION PROCEEDINGS, 1982, 41 (05) : 1665 - 1665
  • [3] ANGIOTENSIN CONVERTING ENZYME (ACE) INDUCTION IN THE RAT BY ENALAPRIL (MK-421)
    JACKSON, B
    CUBELA, R
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (04) : 436 - 436
  • [4] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    DAVIES, RO
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 303 - 314
  • [5] EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    SACKEL, H
    CHAROCOPOS, F
    DAVIES, RO
    CLINICAL SCIENCE, 1981, 61 : S281 - S283
  • [6] REVERSIBLE LEUCOPENIA ASSOCIATED WITH ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421
    STUDER, A
    VETTER, W
    LANCET, 1982, 1 (8269): : 458 - 458
  • [7] ANGIOTENSIN CONVERTING ENZYME-INHIBITION IN TISSUES FROM SPONTANEOUSLY HYPERTENSIVE RATS AFTER TREATMENT WITH CAPTOPRIL OR MK-421
    COHEN, ML
    KURZ, KD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1982, 220 (01): : 63 - 69
  • [8] EFFECTS OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK-421, IN NORMAL MEN AND PATIENTS
    KONO, T
    OSEKO, F
    IKEDA, F
    NAKANO, R
    TANIGUCHI, A
    IMURA, H
    ENDO, J
    ENDOCRINOLOGIA JAPONICA, 1982, 29 (05): : 615 - 622
  • [9] ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421
    GAVRAS, H
    WAEBER, B
    GAVRAS, I
    BIOLLAZ, J
    BRUNNER, HR
    DAVIES, RO
    LANCET, 1981, 2 (8246): : 543 - 547
  • [10] HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421 (ENALAPRIL)
    FOUAD, FM
    TARAZI, RC
    BRAVO, EL
    TEXTOR, SC
    HYPERTENSION, 1984, 6 (02) : 167 - 174
12345